Irish Research Radiation Oncology Group
@IRROGTrials
Unites all public radiotherapy centres and private collaborators, improving access to RT Clinical Trials in Ireland. Patients are the ❤️ of our mission.
Great morning in Hilton Kilmainhan with @IrishCancerSoc @stjamesdublin @ARCCANCERDUBLIN @hseNCCP re Young Onset Cancer and staying patient / person centred. Coping and living beyond cancer @OesophagealCF
A huge thank you to all who joined our IRROG PPI Day on Monday! Patients, advocates & researchers shared vital insights. IRROG & TCD PPI members helped amplify the patient voice in shaping & prioritising upcoming cancer trials nationwide. #PPI #ClinicalTrials #RadiationOncology




Today’s Young Onset event begins with an opening address on Young Onset cancers by Professor @MaeveLowery GI medical oncologist and Co director of the Young onset cancer programme at @CancerInstIRE @IrishCancerSoc
We're delighted this morning to be at @CancerInstIRE's 'Young Onset Cancer in Focus' patient conference. Through a 5-year partnership, the Irish Cancer Society is investing in a first-of-its-kind programme of dedicated wraparound supports for young onset patients aged 25-50.
Prof Maeve Lowry and @KeohaneNicola opening the Young Onset Cancer in Focus Event. @CancerInstIRE @IrishCancerSoc Brilliant to see this event advocating for a model of care for the rising numbers of people under 50 affected by #gastrointestinalcancer and #headandneckcancer.

👏 Congrats to St Luke’s Hospital & @IRROGTrials on enrolling their first patient to the NRG GU012 (SAMURAI) trial for metastatic renal cancer! This @NRGonc study is also open at Beacon Hospital Dublin and explores adding radiation to standard immune therapy:…
Excellent launch of Dr. @BoychackAlex's MICRO GI study in St. Luke's Hospital today. MICRO GI: Assessing feasibility of an RCT investigating the impact of probiotics+dietetic intervention for endometrial ca pts receiving EBRT. #Microbiome #endometrialcancer #probiotics @HSELive

Thanks to @drspdavid for flagging this paper to me Authors suggest that #radiotherapy / #SABR in treatment of oligometastatic disease in trials such as the CURB HALT and AVATAR-2 studies should be termed "strategic radiotherapy" Will it catch on? 🔗sciencedirect.com/science/articl…
Does cancer really know no borders? A new study led by @SiobhanGaynor & @annmcbrien_ , with @Seamusoreilly18 & supported by Cancer Trials Ireland, explores how people with metastatic breast cancer experience care across the island of Ireland: bit.ly/3IIZzZS 📉…
#IrishCancerSociety PPI in Research Award is now open until 27 August 2025 at 3pm. Up to €5,000 funding for cancer researchers of all backgrounds, to support PPI activities in research in Ireland. See our website for info: brnw.ch/21wUbhZ #IrishCancerResearch #PPI
Professor John Armstrong advocating for more cancer clinical trials funding and a national equipmemt replacement programme for all radiation oncology departments. #radiationoncology #clinicaltrials @IrishCancerSoc @cancertrials_ie Important listen: bit.ly/3IHu16B

Congrats to St. Luke's Hospital for randomising the 2nd pt in Ireland on the Samurai Trial. @NRGOncology 1st pt was enrolled in Beacon Hospital. Does adding kidney SABR to immunotherapy improve outcomes for patients whose ca has spread beyond the kidney: vimeo.com/807492124
🎧 Important listen: New figures from @IrishCancerSoc reveal stark regional disparities in access to cancer treatment, with avoidable deaths as a result. Professor John Armstrong, President of the Irish Society of Radiation Oncology, unpacks the findings and calls for action…
The 2025 Cancer Retreat Report has been released. This dynamic community meeting yielded important insights for cancer trials in Ireland. Thanks to all who participated! Access the full report here: bit.ly/3Tw4Whj #CancerTrialsIreland #CancerResearch @Seamusoreilly18…
1st pt in Ireland randomised on the oligomet breast cancer TAORMINA trial in St. Luke's Hospital. Well done to all involved. Thsi trial offers pts the chance to have high dose radiation to discrete areas of cancer spread on this important trial! #breastoncology #clinicaltrials

Results from the international PACE-C prostate cancer trial are now published in The Lancet Oncology: bit.ly/3GgrDDd Cancer Trials Ireland was pleased to support the trial’s opening in ROI as national sponsor. Congrats to Irish co-authors Prof Brian O’Neill & Dr…
Young Onset Cancer Patient event taking place July 25th at the Hilton Hotel , Kilmainham for people who have GI or Head & Neck Cancer (25-50). Attendance limited. To register please see link Young Onset Cancer in Focus Tickets, Fri 25 Jul 2025 at 09:00 | Eventbrite
Huge congratulations, Linda. A crucial paper and one that the HRB-TMRN are delighted to have helped nurture collaborations. We're sure there will be more engagement to follow!
Can a PPI-informed Participant Information Leaflet improve trial recruitment, retention and quality of decision making? Find out in our new paper in Health Expectations doi.org/10.1111/hex.70….
👏🏽👏🏽👏🏽🎉 Such a cool trial! Really proud of @PeterMacRadOnc led trial by @drspdavid - really clinically pragmatic design in oligoprogressive #breastcancer #radonc
🔬 AVATAR trial published(ER+/HER2– MBC on AI + CDK4/6i): In OPD, SABR delayed therapy change (mPFS 9.9 mo) 🔷 44% on same Rx at 12 mo 🔷 36% at 24 mo Some received SABR 2–3× for new oligoprogressions—modified endpoints may better reflect its value. ascopubs.org/doi/10.1200/OA…
🤔 Why are clinical trials important ❓. Super 📽️ from @cancertrials_ie 👇 🙏 to funders @hrbireland @IrishCancerSoc @roinnslainte & our Clinical Trial Units & Patients for their support @gerryhanna @AngelaClaytonL1
💡 Clinical trials start with one powerful question: What if we’re wrong? At Cancer Trials Ireland, we help find better answers to cancer. 🎥 Watch our new video 🗓️ Join our public webinar tomorrow to learn more: bit.ly/4jvt9Q5 #ClinicalTrials #CancerResearch #Webinar…